Antitumor mechanisms of bifidobacteria (Review)

  • Authors:
    • Hongyun Wei
    • Linlin Chen
    • Guanghui Lian
    • Junwen Yang
    • Fujun Li
    • Yiyou Zou
    • Fanggen Lu
    • Yani Yin
  • View Affiliations

  • Published online on: May 10, 2018     https://doi.org/10.3892/ol.2018.8692
  • Pages:3-8
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Cancer remains one of the most common causes of mortality globally. Chemotherapy, one of the major treatment strategies for cancer, primarily functions by targeting the cancer cells and affecting them physiologically, but also affects normal cells, which is a major concern at present. Therefore, adverse effects of chemotherapy drugs, including myelosuppression and liver and kidney damage, are of concern. Now, microbial products have attracted attention in cancer treatment research. Notably, carcinogenesis is considered to be associated with microbial dysbiosis, particularly the positive antitumor effects of bifidobacteria. Although there remains a substantial amount to be understood about the regulation of bifidobacteria, bifidobacteria remain an attractive and novel source of cancer therapeutics. The present review focuses on introducing the latest information on the antitumor effects of bifidobacteria and to propose future strategies for using bifidobacteria in the development of cancer therapeutics.

Related Articles

Journal Cover

July 2018
Volume 16 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wei, H., Chen, L., Lian, G., Yang, J., Li, F., Zou, Y. ... Yin, Y. (2018). Antitumor mechanisms of bifidobacteria (Review). Oncology Letters, 16, 3-8. https://doi.org/10.3892/ol.2018.8692
MLA
Wei, H., Chen, L., Lian, G., Yang, J., Li, F., Zou, Y., Lu, F., Yin, Y."Antitumor mechanisms of bifidobacteria (Review)". Oncology Letters 16.1 (2018): 3-8.
Chicago
Wei, H., Chen, L., Lian, G., Yang, J., Li, F., Zou, Y., Lu, F., Yin, Y."Antitumor mechanisms of bifidobacteria (Review)". Oncology Letters 16, no. 1 (2018): 3-8. https://doi.org/10.3892/ol.2018.8692